PlatoScience ApS

PlatoScience ApS manufactures transcranial direct current stimulation (tDCS) headsets, specifically designed for at-home use. These devices include models like the PlatoCare 1.0 and PW2001-3, which are intended for clinician-led applications in mental health treatment, cognitive focus, and general wellbeing support. The devices incorporate remote monitoring and configuration features to enhance clinical oversight.

PlatoScience ApS is based in Denmark (DK). The company’s regulatory standing is determined by the individual devices it manufactures, not the company itself. For example, its tDCS headsets are registered in the EU’s eudamed database, reflecting compliance with European medical device regulations. The country of origin influences which regulatory frameworks apply, but only specific devices undergo authorisation processes.

PlatoScience ApS’s devices are listed in the eudamed registry, which is the EU’s centralised database for medical devices. This listing is required under EU Medical Device Regulations (MDR) to ensure transparency and traceability of devices marketed in the European Economic Area. Listing confirms the devices meet regulatory requirements, but it does not imply company-wide approval—only individual devices undergo authorisation.

PlatoScience ApS’s tDCS headsets fall under EU medical device classes I and IIa. Classification is based on risk assessment: Class I devices pose minimal risk (e.g., non-invasive, low-energy stimulation), while Class IIa devices involve slightly higher risks (e.g., potential neurological effects requiring clinician guidance). The classification determines regulatory scrutiny, labeling requirements, and post-market surveillance obligations for each device.

PlatoScience ApS’s tDCS headsets are designed for at-home use but under clinician-led supervision, blending consumer accessibility with professional oversight. This dual-purpose design includes remote monitoring and configuration features to ensure safe, personalised use while mitigating risks associated with self-administration. The devices are not purely consumer products (e.g., no OTC claims) nor strictly clinical tools (e.g., not hospital-only), but a hybrid requiring regulatory alignment with both patient safety and medical guidance.